Management of pulmonary hypertension resulting from interstitial lung disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 • 2,715 citations
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension
2002 • 1,382 citations
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
2000 • 1,051 citations
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
2002 • 763 citations
Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis
1999 • 399 citations
Signaling Molecules in Nonfamilial Pulmonary Hypertension
2003 • 397 citations
Severe Pulmonary Hypertension in Histiocytosis X
2000 • 250 citations
Vasoresponsiveness of Sarcoidosis-Associated Pulmonary Hypertension
2001 • 125 citations
Outcomes for Patients With Sarcoidosis Awaiting Lung Transplantation
2002 • 114 citations
Case Report: Vascular Sarcoidosis: A Rare Cause of Pulmonary Hypertension
1983 • 72 citations
Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise
1997 • 59 citations
Sarcoidosis and Reactive Pulmonary Hypertension
1985 • 49 citations
Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation
2001 • 34 citations
Sarcoidosis and reactive pulmonary hypertension
1985 • 8 citations
Effects of infusion of prostacyclin on anatomical intrapulmonary right to left shunt: a useful model of human hypoxic vasoconstriction?
1989 • 4 citations